Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial

…, H Blåfield, M Hakala, K Ilva, U Yli-Kerttula, K Puolakka… - The Lancet, 1999 - thelancet.com
Background The treatment of rheumatoid arthritis should aim at clinical remission. This
multicentre, randomised trial with 2-year follow-up sought evidence on the efficacy and tolerability …

Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic tools

…, G Haugeberg, B Leeb, K Puolakka… - RMD open, 2016 - rmdopen.bmj.com
Treating to target by monitoring disease activity and adjusting therapy to attain remission or
low disease activity has been shown to lead to improved outcomes in chronic rheumatic …

Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease‐modifying antirheumatic drugs: five‐year experience …

…, L Paimela, H Blåfield, K Puolakka… - … : Official Journal of …, 2004 - Wiley Online Library
Objective To evaluate the long‐term frequency of disease remissions and the progression of
joint damage in patients with early rheumatoid arthritis (RA) who were initially randomized …

Early suppression of disease activity is essential for maintenance of work capacity in patients with recent‐onset rheumatoid arthritis: five‐year experience from the FIN …

K Puolakka, H Kautiainen, T Möttönen… - … : Official Journal of …, 2005 - Wiley Online Library
Objective To explore the impact of an early treatment response on maintenance of work
capacity in patients with early, active rheumatoid arthritis (RA). Methods In the Finnish …

Impact of initial aggressive drug treatment with a combination of disease‐modifying antirheumatic drugs on the development of work disability in early rheumatoid …

K Puolakka, H Kautiainen, T Möttönen… - … : Official Journal of …, 2004 - Wiley Online Library
Objective To compare the efficacy of therapy with a combination of disease‐modifying
antirheumatic drugs (DMARDs) versus therapy with a single DMARD in the prevention of work …

[HTML][HTML] Dewey's aesthetics

T Leddy, K Puolakka - 2006 - plato.stanford.edu
John Dewey is, with Charles Sanders Peirce and William James, one of the leading early
figures of the school of American Pragmatists. He has also had a great deal of influence in …

[HTML][HTML] Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early …

…, M Leirisalo-Repo, H Blåfield, K Puolakka… - Arthritis research & …, 2010 - Springer
Introduction Early treatment of rheumatoid arthritis (RA) has been shown to retard the development
of joint damage for a period of up to 5 years. The aim of this study was to evaluate the …

Predictors of productivity loss in early rheumatoid arthritis: a 5 year follow up study

K Puolakka, H Kautiainen, T Möttönen… - Annals of the …, 2005 - ard.bmj.com
Objective: To explore baseline risk factors for productivity loss and work disability over 5 years
in patients with early, active RA. Patients and methods: In the FIN-RACo trial, 195 patients …

Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo …

…, K Ilva, HA Julkunen, L Paimela, K Puolakka… - Annals of the …, 2013 - ard.bmj.com
Objective Early treatment of patients with rheumatoid arthritis (RA) with combination
treatment starting with methotrexate, sulfasalazine, hydroxychloroquine and prednisolone (FIN-…

Rates of serious infections and malignancies among patients with rheumatoid arthritis receiving either tumor necrosis factor inhibitor or rituximab therapy

…, H Valleala, V Rantalaiho, L Pirilä, K Puolakka… - The Journal of …, 2015 - jrheum.org
Objective. Because of the role of tumor necrosis factor (TNF) in host defense, it was hypothesized
that its inhibition might lead to an increased risk of malignancies and infections. The …